Pricing Log in Create free account

Ovid Therapeutics (OVID) vs Prothena Corporation plc (PRTA)

Ovid Therapeutics and Prothena Corporation plc are both Biotechnology companies. Ovid Therapeutics and Prothena Corporation plc are of similar size ($441.4M and $436.4M). Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against 427.3%. Prothena Corporation plc has the higher net margin (−80.7% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 17 metrics below, Prothena Corporation plc leads on 13 and Ovid Therapeutics on 4.

Valuation

Metric OVID PRTA Biotechnology median
P/E n/m n/m 8.50
P/S 54.05 7.98 9.71
P/B 2.02 1.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 40.55 2.70 9.21
Earnings yield (10.48%) (9.94%) (33.15%)
Free cash flow yield (12.94%) (13.96%) (25.50%)

Profitability

Metric OVID PRTA Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (742.97%) (101.80%) 0.00%
Net margin (439.11%) (80.67%) 0.00%
Free cash flow margin (697.30%) (111.49%) 0.00%
Return on equity (25.97%) (14.39%) (56.36%)
Return on assets (22.30%) (12.54%) (48.04%)
Return on invested capital (35.11%) 0.00% 0.00%

Growth

Metric OVID PRTA Biotechnology median
Revenue growth (TTM) 1,333.39% 427.32% 6.02%
EPS growth (last fiscal year) 37.84% (99.56%) 30.26%
Revenue growth, 5-year CAGR (10.48%) 62.56% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OVID PRTA Biotechnology median
Debt to equity 0.05 0.00 0.00
Current ratio 12.39 25.05 4.72
Net debt to EBITDA 1.37 1.46 0.96

Dividend

Metric OVID PRTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OVID PRTA Biotechnology median
Market cap 441.37m 436.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack